SEC Form 4 · accession 0001209191-15-077021
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McFarland
Officer — SVP, General Counsel & Sec.
Period of report
Oct 23, 2015
Accepted (ET)
Oct 27, 2015 · 7:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 23, 2015 | A | 4,000 | $0.00 | A | 7,572 | D | |
| Common StockF2 | Oct 23, 2015 | A | 1,261 | $0.00 | A | 8,833 | D | |
| Common StockF3 | Oct 23, 2015 | F | 473 | $89.29 | D | 8,360 | D | |
| Common Stock | Oct 26, 2015 | M | 834 | $46.08 | A | 9,194 | D | |
| Common StockF5 | Oct 26, 2015 | S | 534 | $85.5235 | D | 8,660 | D | |
| Common StockF6 | Oct 26, 2015 | S | 300 | $86.6367 | D | 8,360 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F7 | $89.29 | Oct 23, 2015 | A | 2,725 | A | — | Oct 23, 2022 | Common Stock | 2,725 | 2,725 | D |
| Employee Stock Option (Right to Buy)F8 | $46.08 | Oct 26, 2015 | M | 834 | D | — | Nov 4, 2020 | Common Stock | 834 | 3,612 | D |
Explanation of responses
- F1One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2015, until fully vested on 10/31/2018.
- F2Reflects shares released October 23, 2015 in connection with the vesting of performance-based market stock units granted on October 24, 2014.
- F3Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.
- F4The shares were sold pursuant to a 10b5-1 Trading Plan dated February 19, 2015.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.17 to $86.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F71/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.
- F8One-third of the total number of shares subject to the option vested and became exercisable on November 4, 2014, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 4th day of each month thereafter until fully vested on November 4, 2016.